Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-13

Clinical Trial Update: Continuation Protocol for Obstructive Sleep Apnea (OSA) [Phase 3]

View source ↗

Summary

This update describes the continuation protocol for a Phase 3 study in obstructive sleep apnea sponsored by Apnimed, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Apnimed | Conditions: OSA | Phase 3 | Status: ENROLLING_BY_INVITATION